Chronic Myeloid Leukemia Registry
The Cancer Support Community’s Research and Training Institute and The Leukemia & Lymphoma Society (LLS) have joined forces to launch the Cancer Experience Registry: Chronic Myeloid Leukemia.
For news archives, click here.
This web site is intended to provide patients, families, physicians and health care workers with extensive information about the Leukemia/Bone Marrow Transplant Program of British Columbia including:
At this time, the Program is only able to offer care to patients residing in Canada. International users may, however, find useful information which they can discuss with their own physicians.
DISCLAIMER: The information on this site is not medical advice. Treatment of individual patients may differ from that described. At all times patients should rely on the advice of their specialist, who is the only person with full information about their diagnosis and medical history.
It is extremely important for all Leukemia/BMT patients to be protected from acquiring Influenza infection. The Leukemia/BMT Program of British Columbia strongly recommends that all patients and close family contacts receive the annual influenza (flu) vaccine.
Exceptions to this recommendation are:
Patients who are between 3 & 6 months post transplant should receive a second dose of vaccine 4 weeks later.
If you are receiving chemotherapy, we recommend that you be vaccinated just prior to your next cycle of chemotherapy.
You should go to your family doctor or health clinic for vaccination, as the vaccine will not be available at the transplant clinic. It is important to note that your platelet count should be greater than 40 x 109/L at the time you receive the vaccination
The nasal spray vaccine ("Flumist") has not been assessed for safety in stem cell transplant
patients and there is a theoretical risk of transmission of live virus with this vaccine.
For this reason, it is recommended that patients being followed by the Leukemia/BMT
Program and their close contacts should NOT receive this vaccine.
Specific questions can be addressed to your BMT physician.